Altravax awarded $1.2M to advance dengue vaccine and hep B therapeutic January 11, 2013 CenterWatch Staff
Cyberonics names KenKnight as vice president of emerging therapies January 11, 2013 CenterWatch Staff
BioCrossroads Indiana Seed Fund II makes first investments in start-ups January 11, 2013 CenterWatch Staff
CoDa boasts positive results in phase IIb study of Nexagon in chronic venous leg ulcers January 10, 2013 CenterWatch Staff
Mystery shopper campaign highlights NHS shortcomings in promoting clinical research January 10, 2013 CenterWatch Staff